Financial Instruments - Additional Information (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013		Dec. 31, 2012	Dec. 31, 2011
Fair Value Measurements Of Financial Instruments [Line Items]
Revaluation of derivative financial instruments, tax	$ (2.3)	$ 1.0		$ 0
Standby and trade letters of credit for various corporate purposes	9.0	9.9
Accumulated other comprehensive loss	(243.2)	(149.8)	[1]	(208.2)	(200.9)
Standby Letters Of Credit Which Support Products Corporations Self Insurance Programs
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes	7.7	8.1
Foreign exchange contracts
Fair Value Measurements Of Financial Instruments [Line Items]
Derivative, notional amount	7.6	52.9
Interest Rate Swap
Fair Value Measurements Of Financial Instruments [Line Items]
Derivative, notional amount	400.0
Term of contract	3 years
Floor interest rate (percent)	1.00%
Fixed interest rate (percent)	2.0709%
Fixed interest rate on debt (percent)	5.0709%
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	(1.3)
Total
Fair Value Measurements Of Financial Instruments [Line Items]
Fair value of assets	0.2	3.5
Deferred Gain - Hedging
Fair Value Measurements Of Financial Instruments [Line Items]
Accumulated other comprehensive loss	$ (2.2)	$ 1.5		$ 0	$ 0

[1] During the year ended December 31, 2014, the Company recorded Measurement Period Adjustments (as hereinafter defined) to certain net assets and intangible assets acquired in the Colomer Acquisition (as hereinafter defined) on October 9, 2013. Accordingly, the prior period has been retrospectively adjusted for such Measurement Period Adjustments. Refer to Note 2, "Business Combination" for additional details.